舒華體育(605299.SH):首發募投項目擬結項 節餘資金永久補充流動資金
格隆匯7月19日丨舒華體育(605299.SH)公佈,公司於2021年7月19日召開第三屆董事會第十六次會議、第三屆監事會第十次會議審議通過了《關於公司首次公開發行股票募集資金投資項目結項並將節餘募集資金永久補充流動資金的議案》,公司首次公開發行股票募集資金投資“二期生產基地建設項目”、“研發中心建設項目”、“信息化建設項目”已達到預定可使用狀態,為提高節餘募集資金使用效率,擬將上述募投項目結項後的節餘募集資金7701.9萬元(實際金額以資金轉出當日專户餘額為準)永久補充流動資金,獨立董事發表了明確的同意意見。該議案需提交公司股東大會審議,
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.